IL58730A - Spiro-polycyclic imidazolidinedione derivatives and pharmaceutical compositions containing them - Google Patents

Spiro-polycyclic imidazolidinedione derivatives and pharmaceutical compositions containing them

Info

Publication number
IL58730A
IL58730A IL58730A IL5873079A IL58730A IL 58730 A IL58730 A IL 58730A IL 58730 A IL58730 A IL 58730A IL 5873079 A IL5873079 A IL 5873079A IL 58730 A IL58730 A IL 58730A
Authority
IL
Israel
Prior art keywords
spiro
polycyclic
pharmaceutical compositions
compositions containing
imidazolidinedione derivatives
Prior art date
Application number
IL58730A
Other languages
English (en)
Other versions
IL58730A0 (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of IL58730A0 publication Critical patent/IL58730A0/xx
Publication of IL58730A publication Critical patent/IL58730A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
IL58730A 1978-11-16 1979-11-15 Spiro-polycyclic imidazolidinedione derivatives and pharmaceutical compositions containing them IL58730A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/961,335 US4181728A (en) 1978-11-16 1978-11-16 Spiro-polycyclicimidazolidinedione derivatives

Publications (2)

Publication Number Publication Date
IL58730A0 IL58730A0 (en) 1980-02-29
IL58730A true IL58730A (en) 1984-01-31

Family

ID=25504341

Family Applications (1)

Application Number Title Priority Date Filing Date
IL58730A IL58730A (en) 1978-11-16 1979-11-15 Spiro-polycyclic imidazolidinedione derivatives and pharmaceutical compositions containing them

Country Status (23)

Country Link
US (1) US4181728A (fi)
JP (2) JPS6052157B2 (fi)
AR (1) AR222052A1 (fi)
AT (1) AT369742B (fi)
AU (1) AU515301B2 (fi)
BE (1) BE880065A (fi)
CA (1) CA1125294A (fi)
CH (1) CH642358A5 (fi)
DE (1) DE2946037A1 (fi)
DK (1) DK484479A (fi)
ES (1) ES486007A1 (fi)
FI (1) FI66385C (fi)
FR (1) FR2441627A1 (fi)
GB (1) GB2038315B (fi)
IE (1) IE49116B1 (fi)
IL (1) IL58730A (fi)
IT (1) IT1127231B (fi)
LU (1) LU81890A1 (fi)
NL (1) NL177689C (fi)
PH (1) PH15672A (fi)
PT (1) PT70452A (fi)
SE (1) SE447731B (fi)
YU (1) YU41678B (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
ATE10940T1 (de) * 1981-05-12 1985-01-15 Imperial Chemical Industries Plc Pyrrolderivate.
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
IL68314A0 (en) * 1982-04-15 1983-07-31 Alcon Lab Inc Method and composition for inhibiting aldose reductase activity and process for preparing spirofluorofluoren and spiro-difluorofluoren compounds
JPS59500618A (ja) * 1982-04-15 1984-04-12 アルコン・ラボラトリ−ズ・インコ−ポレ−テッド スピロ―フルオロフルオレン化合物、その製造法およびアルド―スレダクターゼ活性を阻害する組成物
DE3342933A1 (de) * 1983-11-26 1985-06-05 Horst G. 5190 Stolberg Schumann Regalfoerderzeug
US4717725A (en) * 1984-04-11 1988-01-05 Alcon Laboratories, Inc. Ophthalmic wound healing with aldose reductase inhibitors
US4600717A (en) * 1984-04-11 1986-07-15 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in ophthalmic wound healing
US4609663A (en) * 1984-09-11 1986-09-02 Alcon Laboratories, Inc. Aldose reductase inhibitors useful in glaucoma therapy
US4576143A (en) * 1984-10-05 1986-03-18 Clark Iii William T Method of immune modification by means of extracorporeal irradiation of the blood
US5340829A (en) * 1984-11-20 1994-08-23 Washington Research Foundation Immunoregulatory agents
US4966911A (en) * 1984-11-20 1990-10-30 Washington Research Foundation Immunoregulatory agents
JPS6372140U (fi) * 1986-10-29 1988-05-14
JPS63119451U (fi) * 1987-01-30 1988-08-02
WO1992000071A1 (en) * 1989-02-10 1992-01-09 Washington Research Foundation Immunoregulatory agents

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2683718A (en) * 1952-01-11 1954-07-13 Searle & Co Spiro-[xanthene-9, 4'-imidazolidine]-2, 5-dione
DE1032257B (de) * 1954-05-27 1958-06-19 Cutter Lab Verfahren zur Herstellung neuer Hydantoine
GB796069A (en) * 1955-12-23 1958-06-04 Ici Ltd Substituted hydantoins
GB818724A (en) * 1956-10-18 1959-08-19 Ici Ltd Hydantoin derivatives
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
US4078064A (en) * 1976-08-18 1978-03-07 E. R. Squibb & Sons, Inc. 8H-Pyrazolo[4',3':5,6]pyrido[3,4-e][1,2,4]triazolo[1,5-a]pyrimidines
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents
US4117230A (en) * 1976-10-18 1978-09-26 Pfizer Inc. Hydantoin derivatives as therapeutic agents
US4130714A (en) * 1977-05-23 1978-12-19 Pfizer Inc. Hydantoin therapeutic agents
US4127665A (en) * 1978-01-18 1978-11-28 Pfizer Inc. Thienohydantoin derivatives

Also Published As

Publication number Publication date
JPS6144868B2 (fi) 1986-10-04
FI66385B (fi) 1984-06-29
FI793586A (fi) 1980-05-17
NL177689C (nl) 1985-11-01
PT70452A (en) 1979-12-01
CH642358A5 (fr) 1984-04-13
SE447731B (sv) 1986-12-08
ATA729779A (de) 1982-06-15
CA1125294A (en) 1982-06-08
FR2441627B1 (fi) 1983-06-03
PH15672A (en) 1983-03-11
LU81890A1 (fr) 1980-06-05
US4181728A (en) 1980-01-01
YU277379A (en) 1983-01-21
IE792184L (en) 1980-05-16
AR222052A1 (es) 1981-04-15
AU5288079A (en) 1980-05-22
FR2441627A1 (fr) 1980-06-13
ES486007A1 (es) 1980-09-01
YU41678B (en) 1987-12-31
DK484479A (da) 1980-05-17
IL58730A0 (en) 1980-02-29
IT7927311A0 (it) 1979-11-15
NL7908352A (nl) 1980-05-20
BE880065A (fr) 1980-05-16
AU515301B2 (en) 1981-03-26
IT1127231B (it) 1986-05-21
NL177689B (nl) 1985-06-03
DE2946037A1 (de) 1980-05-22
FI66385C (fi) 1984-10-10
GB2038315B (en) 1982-08-11
JPS60120870A (ja) 1985-06-28
GB2038315A (en) 1980-07-23
JPS5589268A (en) 1980-07-05
IE49116B1 (en) 1985-08-07
JPS6052157B2 (ja) 1985-11-18
SE7909439L (sv) 1980-05-17
AT369742B (de) 1983-01-25

Similar Documents

Publication Publication Date Title
NZ189378A (en) 4-amino-5-alkylsulphonyl-ortho-anisamdes and pharmaceutical compositions
IL56556A (en) Pharmaceutical compositions comprising imidazole derivatives and certain such novel compounds
PH14086A (en) Cyclosporin derivatives and pharmaceutical compositions thereof
IL57450A0 (en) Aminothiazole derivatives and pharmaceutical compositions containing them
NZ190784A (en) Benzofuranyl-piperidines and pharmaceutical compositions
IL56407A (en) 4-amino-3-sulfamoylpyridyl derivatives and pharmaceutical compositions containing them
NZ193798A (en) 3-thiovinyl-cephalosporin derivatives and pharmaceutical compositions
IL57849A (en) Imidazole derivatives and pharmaceutical compositions containing same
IL58730A0 (en) Spiro-polycyclic imidazolidinedione derivatives and pharmaceutical compositions containing them
IL57268A0 (en) Di-o-n-alkyl clycerol derivatives and pharmaceutical compositions containing them
IL60376A0 (en) 3-methyleneazetidine derivatives and pharmaceutical compositions containing them
IL58620A0 (en) Aryltrifluoroethanol derivatives their preparation and pharmaceutical compositions containing them
NZ189899A (en) Dilignols and dilignol-type compounds pharmaceutical compositions
NZ192142A (en) Cephalosporin derivatives and pharmaceutical compositions
NZ190245A (en) Isoquinoline derivatives and pharmaceutical compositions containing them
NZ189769A (en) Benzylidene derivatives and pharmaceutical compositions
NZ189279A (en) Arylaminoimidazolines and pharmaceutical compositions
IL57436A0 (en) Hydantoin derivatives and pharmaceutical compositions containing them
IL57882A (en) 2-thiophenecarboxamido-alkyl-mercaptans and pharmaceutical compositions containing them
IL60695A0 (en) Hexahydro-trans-pyridoindole derivatives and pharmaceutical compositions containing them
IL61038A (en) 15-sulfonamidoprostaglandin derivatives and pharmaceutical compositions containing them
IL60040A0 (en) Imidazole derivatives and pharmaceutical compositions containing them
NZ190293A (en) Benzimidoyl-piperazines and pharmaceutical compositions
NZ190007A (en) Steroid-spiro-oxazolidinone derivatives and pharmaceutical compositions
NZ190665A (en) S-benzylcysteine derivatives and pharmaceutical compositions

Legal Events

Date Code Title Description
RH Patent void